Meeting
2012 Gastrointestinal Cancers Symposium
Relationship of myeloid-derived suppressor cells (MDSC) and immune suppression, nutritional impairment, and inflammatory markers in patients with gastrointestinal cancer.
Authors
Masahiko Shibata
Fukushima Medical University, Fukushima, Japan
Masahiko Shibata , Kenji Gonda , Izumi Nakamura , Shinji Ohki , Kenichi Sakurai , Tatsuo Shimura , Seiichi Takenoshita
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session C: Cancers of the Colon and Rectum
Track
Cancers of the Colon, Rectum, and Anus
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 30, 2012 (suppl 4; abstr 675)
DOI
10.1200/jco.2012.30.4_suppl.675
Abstract #
675
Poster Bd #
G12
Abstract Disclosures
Similar Posters
Poster
2014 ASCO Annual Meeting
Pretreatment serum levels of circulating myeloid-derived suppressor cells (MDSC) as a prognostic indicator in patients with gastrointestinal cancer.
First Author: Masahiko Shibata
Poster
2014 Gastrointestinal Cancers Symposium
Serum levels of vascular endothelial growth factor in patients with gastrointestinal cancers and correlation with malnutrition, immunosuppression involving MDSC, and systemic inflammation.
First Author: Kenji Gonda
Poster
2013 Gastrointestinal Cancers Symposium
Correlation of production of IL-17 with immune suppression relating myeloid-derived suppressor cells (MDSC) and nutritional damages in patients with digestive system cancer.
First Author: Kenji Gonda
Poster
2024 ASCO Breakthrough
The dynamic changes of circulating myeloid-derived suppressor cells (MDSCs) subsets in patients with colorectal cancer undergoing oxaliplatin-based chemotherapy.
First Author: Dilafitria Fauza